| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.1 | 0.02 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.12 | 0.02 |